₹47.35 -2.7 (-5.39%)
22 Feb, 2025 21:33
Start SIP in
SAROJA
Performance
- Low
- ₹47
- High
- ₹49
- 52 Week Low
- ₹33
- 52 Week High
- ₹71
- Open Price₹48
- Previous Close₹50
- Volume6,400
Investment Returns
- Over 1 Month -13.91%
- Over 3 Month -18.29%
- Over 6 Month -1.87%
- Over 1 Year -3.56%
Smart Investing Starts Here Start SIP with Saroja Pharma Industries India for Steady Growth!
Saroja Pharma Industries India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.7
- PEG Ratio
- -
- Market Cap Cr
- 19
- P/B Ratio
- 1.3
- Average True Range
- 2.32
- EPS
- 2.18
- Dividend Yield
- 0
- MACD Signal
- -0.72
- RSI
- 37.83
- MFI
- 46.71
Saroja Pharma Industries India Financials
Saroja Pharma Industries India Technicals
EMA & SMA
Current Price
₹47.35
-2.7
(-5.39%)

-
- Bullish Moving Average 0
-
- Bearish Moving Average 16
- 20 Day
- ₹53.04
- 50 Day
- ₹54.03
- 100 Day
- ₹53.28
- 200 Day
- ₹52.87
Resistance and Support
47.9
- R3 50.10
- R2 49.55
- R1 48.45
- S1 46.80
- S2 46.25
- S3 45.15
Saroja Pharma Industries India Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-13 | Quarterly Results | |
2024-05-29 | Audited Results |
Saroja Pharma Industries India F&O
About Saroja Pharma Industries India
- NSE Symbol
- SAROJA
- BSE Symbol
- Chairman & Managing Director
- Mr. Biju Gopinathan Nair
- ISIN
- INE0PCL01011
Similar Stocks to Saroja Pharma Industries India
Saroja Pharma Industries India FAQs
Saroja Pharma Industries India share price is ₹47 As on 22 February, 2025 | 21:19
The Market Cap of Saroja Pharma Industries India is ₹19 Cr As on 22 February, 2025 | 21:19
The P/E ratio of Saroja Pharma Industries India is 21.7 As on 22 February, 2025 | 21:19
The PB ratio of Saroja Pharma Industries India is 1.3 As on 22 February, 2025 | 21:19
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.